MiMedx Group Inc (MDXG)
7.29
+0.16
(+2.24%)
USD |
NASDAQ |
May 07, 16:00
7.29
0.00 (0.00%)
After-Hours: 19:09
MiMedx Group Enterprise Value: 1.023B for May 6, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 06, 2024 | 1.023B |
| May 03, 2024 | 1.059B |
| May 02, 2024 | 1.078B |
| May 01, 2024 | 1.050B |
| April 30, 2024 | 880.21M |
| April 29, 2024 | 894.97M |
| April 26, 2024 | 896.44M |
| April 25, 2024 | 892.75M |
| April 24, 2024 | 920.06M |
| April 23, 2024 | 931.73M |
| April 22, 2024 | 909.60M |
| April 19, 2024 | 899.26M |
| April 18, 2024 | 880.08M |
| April 17, 2024 | 905.17M |
| April 16, 2024 | 890.41M |
| April 15, 2024 | 908.12M |
| April 12, 2024 | 921.40M |
| April 11, 2024 | 946.49M |
| April 10, 2024 | 937.64M |
| April 09, 2024 | 1.007B |
| April 08, 2024 | 989.29M |
| April 05, 2024 | 1.004B |
| April 04, 2024 | 1.007B |
| April 03, 2024 | 1.005B |
| April 02, 2024 | 985.96M |
| Date | Value |
|---|---|
| April 01, 2024 | 1.070B |
| March 31, 2024 | 1.107B |
| March 28, 2024 | 1.098B |
| March 27, 2024 | 1.084B |
| March 26, 2024 | 1.086B |
| March 25, 2024 | 1.117B |
| March 22, 2024 | 1.148B |
| March 21, 2024 | 1.165B |
| March 20, 2024 | 1.171B |
| March 19, 2024 | 1.149B |
| March 18, 2024 | 1.124B |
| March 15, 2024 | 1.124B |
| March 14, 2024 | 1.112B |
| March 13, 2024 | 1.134B |
| March 12, 2024 | 1.140B |
| March 11, 2024 | 1.142B |
| March 08, 2024 | 1.165B |
| March 07, 2024 | 1.164B |
| March 06, 2024 | 1.152B |
| March 05, 2024 | 1.142B |
| March 04, 2024 | 1.180B |
| March 01, 2024 | 1.234B |
| February 29, 2024 | 1.165B |
| February 28, 2024 | 1.171B |
| February 27, 2024 | 1.201B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
274.21M
Minimum
Dec 19 2022
1.735B
Maximum
Sep 08 2021
697.12M
Average
653.39M
Median
Enterprise Value Benchmarks
| TELA Bio Inc | 106.70M |
| Amylyx Pharmaceuticals Inc | -236.81M |
| CEL-SCI Corp | 89.60M |
| AIM ImmunoTech Inc | 8.578M |
| IGC Pharma Inc | 31.32M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 9.261M |
| Revenue (Quarterly) | 84.71M |
| Total Expenses (Quarterly) | 71.46M |
| EPS Diluted (Quarterly) | 0.06 |
| Gross Profit Margin (Quarterly) | 84.67% |
| Profit Margin (Quarterly) | 10.93% |
| Earnings Yield | 6.86% |
| Operating Earnings Yield | 5.55% |
| Normalized Earnings Yield | 6.932 |